Sulfateq BV | Empowering health
  • Home
  • About us
  • Programs & Pipeline
  • Scientific data
  • Partnering
    • Investors
  • Newsroom
  • Contact us
Select Page

The Sulfateq compound SUL-121 is proven to potentially contribute to the treatment of COPD

by Raymond Tel | Jun 8, 2015 | COPD, Events, Hibernation, News, Poster release, Treatment

We are proud to announce that one of our SUL-compounds, SUL-121, is proven to have both an anti-inflammatory and bronchodilating effect in vitro and in vivo. In the study, performed by the University of Groningen, the researchers explored the anti-inflammatory and...

Poster presented on FIGON Dutch Medicines Days 2014

by Raymond Tel | Nov 12, 2014 | Events, FIGON Days, Poster release

Colleague Pieter Vogelaar has presented our poster no. 97 “A new class of compounds for the protection of cells during storage at 2- 8°C” on de FIGON Dutch Medicines Days, held on 6-8 October 2014 in Ede, the Netherlands. Two more posters & one presentation...

5 tips on how to update your knowledge of Innovative Drug Research in just 3 days

by Raymond Tel | Nov 6, 2014 | FIGON Days, Poster release

Next Monday, Tuesday and Wednesday, drug development will be the key issue in Ede, the Netherlands. It’s time for the 16th edition of the FIGON Dutch Medicines Days (www.figondmd.nl), a prestigious event focussing on the most recent innovations in healthcare and...
  • RSS
Sulfateq BV - Copyright 2021